Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors
Open Access
- 28 February 2005
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 11 (2) , 320-326
- https://doi.org/10.1016/j.ymthe.2004.08.030
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liverGene Therapy, 2003
- In vitro selection of viral vectors with modified tropism: the adeno-associated virus displayMolecular Therapy, 2003
- Receptor targeting of adeno-associated virus vectorsGene Therapy, 2003
- Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6Molecular Therapy, 2003
- Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyProceedings of the National Academy of Sciences, 2002
- Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad SpecificityJournal of Virology, 2002
- Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype VectorsMolecular Therapy, 2000
- Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous systemProceedings of the National Academy of Sciences, 2000
- Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA.Proceedings of the National Academy of Sciences, 1994
- Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.Proceedings of the National Academy of Sciences, 1984